EUVIMEDDescoperă EUVIMED
EUVIMED · CrossrefJournal

The Oncologist

ISSN 1083-7159 · Oxford University Press (OUP)

Latest articles

  1. Blood Cell Count Ratios Predict Immune-related Adverse Events in Metastatic Renal Cell Carcinoma Treated With First-Line Immune Checkpoint Inhibitors

    Rahul Winayak, Kaela Makins, Xiaochen Li, Nicholas J Salgia, Ali Moradi, Vitor Abreu de Goes, Salvador Jaime-Casas, Koral U Shah, Miguel Zugman, Regina Barragan-Carrillo, Jadon C Fann, George Zhang, Benjamin Mercier, Yu Jun Li, Daniela V Castro, Hedyeh Ebrahimi, Nazli Dizman, JoAnn Hsu, Abhishek Tripathi, Alexander Chehrazi-Raffle, Tanya Dorff, Sumanta Kumar Pal

    Published: 2026-11-14DOI: 10.1093/oncolo/oyag454

  2. Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinations

    Giulia Claire Giudice, Hassan Mohammed Abushukair, Giulia Mazzaschi, Pietro Tuttobene, Michele Maffezzoli, Letizia Gnetti, Nicoletta Campanini, Giacomo Iovane, Fabiana Perrone, Monica Pluchino, Elena Rapacchi, Giada Pinterpe, Stefano Travaglini, Rosedwige Marchitelli, Tae Gyu Oh, Abdul Rafeh Naqash, Matteo Santoni, Elisa Araldi, Roberto Pili, Riccardo Perrone, Francesco Potì, Rossana Berardi, Federica Pecci, Sebastiano Buti

    Published: 2026-11-06DOI: 10.1093/oncolo/oyag430

  3. Tumor Longevity: a time-dependent biomarker of immune checkpoint inhibitor responsiveness across head and neck, lung, renal and urothelial cancers

    Rebecca Romanò, Chiara Airoldi, Salvatore Alfieri, Anna Piemontese, Silvia Pierri, Gabriele Calvanese, Daniele Piscazzi, Gabriele Ciarlo, Diego Signorelli, Elio Gregory Pizzutilo, Giulio Cerea, Laura Giannetta, Annalisa Zeppellini, Giorgio Patelli, Silvia Buriolla, Simone Rota, Federica Manoni, Noemi Crippa, Cecilia Silvestri, Simone Oldani, Sabina Sangaletti, Rosalba Miceli, Andrea Sartore-Bianchi, Salvatore Siena, Lisa Licitra

    Published: 2026-11-06DOI: 10.1093/oncolo/oyag445

  4. A phase 2 study of tipifarnib in children and young adults with tumors harboring HRAS genomic alterations: NCI-COG Pediatric MATCH trial (APEC1621M)

    Christine A Pratilas, Marielle E Yohe, Paul M Williams, Joel M Reid, Jin Piao, Lauren Saguilig, David R Patton, Brent Coffey, Todd A Alonzo, Alexandria M Thompson, Nicole Arwood, Sinchita Roy-Chowdhuri, Nilsa C Ramirez, Stacey L Berg, Elizabeth Fox, Brenda J Weigel, Douglas S Hawkins, Margaret M Mooney, Naoko Takebe, James V Tricoli, Katherine A Janeway, Nita L Seibel, Donald W Parsons

    Published: 2026-11-05DOI: 10.1093/oncolo/oyag401

  5. Reference frame for adult brainstem gliomas

    Florence Laigle-Donadey, Emmanuel Mesny, Franck Bielle, Aurélie Kas, Lucia Nichelli, Carole Ramirez, Laura Rozenblum, Olivier Langlois, Guido Ahle, Luc Bauchet, Loic Feuvret, Maxime Fontanilles, Julien Savatovsky, Jean-Marc Constans, Nadya Pyatigorskaya, Mehdi Touat, Julian Jacob, Emmanuel Jouglar, Luc Ollivier, Elsa Magro, Matthieu Boone, Apolline Monfilliette, Enora Vauleon, Philippe Menei, Ahmed Idbaih, Jean-Sébastien Guillamo, Elodie Vauleon, François Ducray, Caroline Dehais, Sylvie Grand, Bertrand Mathon, Fabien Almeirac, Alice Bonneville-Levard, Mathieu Boone, Véronique Bourg, Charlotte Bronnimann, Marie-Dominique Cantal-Dupart, Hélène Castel Gandolfo, Olivier Chinot, Jean Marc Constans

    Published: 2026-11-05DOI: 10.1093/oncolo/oyag403

  6. Site-specific outcomes and genomics in metastatic pancreatic ductal adenocarcinoma

    Mahmoud Yousef, Saikat Chowdhury, Sali Albarouki, Ahmed Elhariri, Guglielmo Vetere, Sacha El Khoury, Mohammad Fanaeian, Abdelrahman Yousef, Ashwathy Balachandran Pillai, Kristin Alfaro-Munoz, Mark Knafl, Paul Roy, Mark W Hurd, Brandon G Smaglo, Robert A Wolff, Shubham Pant, Jason Willis, Ryan Huey, Michael J Overman, Camila Lopez, Anthony Chen, Ethan B Ludmir, Eugene J Koay, Rebecca A Snyder, Ching-Wei Tzeng, Michael P Kim, Naruhiko Ikoma, Jessica E Maxwell, Huamin Wang, Anirban Maitra, Matthew H G Katz, Yang Chen, Haoqiang Ying, John Paul Shen, Dan Zhao

    Published: 2026-11-05DOI: 10.1093/oncolo/oyag423

  7. Immunotherapy and cancer: the CIPOMO viewpoint on challenges and opportunities

    Giuseppe Aprile, Donatella Iacono, Sandro Barni, Monica Giordano, Cinzia Ortega, Rosa Rita Silva, Paolo Tralongo, Luisa Fioretto, Giuseppe Aprile, Monica Giordano, Cinzia Ortega, Rosa Rita Silva, Giovanni Pietro Ianniello, Katia Cannita, Clementina Savastano, Antonio Iaria, Fabrizio Artioli, Alessandro Follador, Teresa Gamucci, Carlo Aschele, Andrea De Monte, Renato Bisonni, Roberta Buosi, Silvana Leo, Maria Giuseppina Sarobba, Stefano Vitello, Angela Stefania Ribecco, Orazio Caffo, Riccardo Rossetti, Teodoro Sava, Luigi Cavanna, Alberto Scanni, Luisa Fioretto

    Published: 2026-11-05DOI: 10.1093/oncolo/oyag435

Volumes

2026 · 6552025 · 6742024 · 4062023 · 3272022 · 2862021 · 4652020 · 4482019 · 4152018 · 2592017 · 2392016 · 2342015 · 2602014 · 2162013 · 2492012 · 2542011 · 2552010 · 2082009 · 1752008 · 1952007 · 1902006 · 1582005 · 1392004 · 1292003 · 1152002 · 1622001 · 1512000 · 1151999 · 691998 · 681997 · 861996 · 70

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.